Codes / ICD10CM / T50.7X3A

T50.7X3A Poisoning by analeptics and opioid receptor antagonists, assault, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by analeptics and opioid receptor antagonists, assault, initial encounter

Summary

This condition involves harmful effects resulting from exposure to analeptics (stimulant medications) or opioid receptor antagonists (drugs that block opioid effects) due to assault during the initial encounter. It includes poisoning or adverse reactions caused by intentional administration of these substances by another party, which can disrupt central nervous system function, respiratory regulation, and opioid-related pathways.

Causes

Exposure typically results from deliberate administration of these medications by another individual, often as part of an assault. Therapeutic errors or drug interactions may exacerbate effects, but the primary cause is intentional action by a third party during the initial encounter.

Risk Factors

  • Exposure to environments where assault is possible (e.g., violent or unsafe settings)
  • Lack of supervision or control over medication access in vulnerable situations
  • Concurrent use of medications altering CNS activity or opioid effects
  • Underlying conditions requiring analeptic or antagonist therapy (increasing target for assault)

Symptoms

  • Central nervous system effects (e.g., agitation, seizures, sedation, confusion)
  • Respiratory changes (e.g., tachypnea, respiratory depression, or paradoxical stimulation)
  • Cardiovascular instability (e.g., hypertension, hypotension, arrhythmias)
  • Gastrointestinal disturbances (nausea, vomiting)
  • Altered mental status or confusion

Diagnosis

Diagnosis involves patient history to identify assault as the cause, clinical assessment of symptoms, and toxicology screening to confirm exposure to analeptics or opioid receptor antagonists. Documentation must specify the assault context and initial encounter status.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms (e.g., airway support, cardiovascular monitoring), and addressing the toxic effects of the substances. Interventions may include antidotes, supportive care, and psychological evaluation.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure, timely treatment, and underlying health. Follow-up includes monitoring for delayed effects, assessing for complications, and coordinating with mental health or social services as needed.

Complications

  • Respiratory failure or arrest
  • Seizures or neurological damage
  • Cardiovascular collapse
  • Psychological trauma from the assault

Lifestyle & Prevention

  • Avoid high-risk environments or situations where assault is possible
  • Ensure secure storage of medications to prevent unauthorized access
  • Seek support from safety resources or protective services if at risk

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, especially after suspected assault. Contact emergency services for acute respiratory distress, altered consciousness, or cardiovascular instability.

Tips for Medical Coders

Document the assault context and initial encounter clearly. Code T50.7X3A requires specifying the intentional nature of exposure and the initial phase of care. Ensure clinical documentation aligns with the code’s definition to support accurate coding.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T50.7X3A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.